Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group trial E2297

Jordan D. Berlin*, Paul Catalano, James P. Thomas, John W. Kugler, Daniel G. Haller, Al Bowen Benson

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

660 Scopus citations

Fingerprint Dive into the research topics of 'Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group trial E2297'. Together they form a unique fingerprint.

Medicine & Life Sciences